Prenetics Global Limited
PRE
$9.02
-$0.24-2.59%
NASDAQ
| 12/31/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 131.21% | 64.02% | -167.31% | -142.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 131.21% | 64.02% | -167.31% | -142.09% |
| Cost of Revenue | -- | 127.91% | 34.47% | -162.06% | -139.54% |
| Gross Profit | -- | 135.79% | 141.99% | -173.86% | -146.26% |
| SG&A Expenses | -- | -63.72% | -66.00% | -93.62% | -88.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 109.99% | -177.63% | -706.69% | -2,225.19% |
| Total Operating Expenses | -- | -25.28% | -54.93% | -120.84% | -109.57% |
| Operating Income | -- | 71.29% | 64.98% | 9.73% | 45.28% |
| Income Before Tax | -- | 73.88% | 73.93% | 69.52% | 75.77% |
| Income Tax Expenses | -- | 82.01% | 37.49% | -243.89% | -265.41% |
| Earnings from Continuing Operations | -- | 73.80% | 73.97% | 72.07% | 76.55% |
| Earnings from Discontinued Operations | -- | -422.33% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 240.99% | -- | -- | 40,533.33% |
| Net Income | -- | 63.73% | 67.07% | 84.10% | 86.75% |
| EBIT | -- | 71.29% | 64.98% | 9.73% | 45.28% |
| EBITDA | -- | 72.81% | 65.94% | 4.38% | 42.86% |
| EPS Basic | -- | 88.03% | 90.55% | 99.88% | 99.61% |
| Normalized Basic EPS | -- | 98.84% | 98.84% | 98.13% | 99.56% |
| EPS Diluted | -- | 87.87% | 90.44% | 99.88% | 99.61% |
| Normalized Diluted EPS | -- | 98.84% | 98.84% | 98.13% | 99.56% |
| Average Basic Shares Outstanding | -- | 97.84% | 196.91% | 271.17% | 355.52% |
| Average Diluted Shares Outstanding | -- | 97.84% | 196.91% | 271.17% | 355.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |